Ultrasound Guided
Joint Injections
- •
Most injections can be accomplished using a high-frequency linear ultrasound transducer.
- •
Ultrasound allows evaluation of the three elbow articulations (radiocapitellar, ulnotrochlear, and proximal radioulnar).
- •
Imaging of the posterior olecranon recess with the elbow in flexion is the most sensitive means to identify pathologic fluid.
Pertinent Anatomy
- •
The elbow joint is a synovial hinged joint consisting of an articulation between the humerus, radius, and ulna.
- •
The joint allows flexion at the elbow and forearm supination and pronation.
- •
The joint can be accessed from a medial, lateral, anterior, or posterior approach ( Fig. 17.1 ).
Common Pathology
- •
Three primary patterns of arthritis can affect the elbow joint: rheumatoid (inflammatory), post-traumatic, and primary osteoarthritis. Intra-articular pathology can present with a joint effusion, synovitis, and associated intra-articular bodies.
- •
Stiffness, restriction of elbow extension, and painful mechanical symptoms are common symptoms associated with arthritis. Pain is typically deep or diffuse, and may present without any palpable tenderness.
Equipment
- •
Needle size: 25- or 27-gauge 1- or 1.5-inch needle.
- •
High-frequency linear ultrasound transducer.
Common Injectates
- •
Local anesthetics for diagnostics, corticosteroids.
- •
Prolotherapy, orthobiologics (platelet-rich plasma [PRP] bone marrow concentrate, etc.).
Injectate Volume
- •
2 to 3 mL
Technique: Lateral Approach
Patient Position
- •
Seated or supine.
- •
Elbow is flexed 40 degrees and the forearm is pronated with palm resting on the table ( Fig. 17.2 ).
Clinician Position
- •
Seated or standing directly next to the elbow being injected.
Transducer Orientation
- •
Long-axis to the radius over the radiocapitellar joint.
Needle Orientation
- •
In-plane to the transducer
- •
Or out-of-plane and short-axis to the transducer
Target
- •
In-plane: directed from distal to proximal into the radiocapitellar joint.
- •
Short axis: start in center of probe and direct into joint directly below transducer.
- •
See the injectate expand the joint without soft tissue distention.
Technique: Posterior Approach
Patient Position
- •
Prone position.
- •
Elbow is flexed approximately 90 degrees and the forearm is hanging over the table ( Fig. 17.3 ).
Clinician Position
- •
Seated or standing directly next to the elbow being injected.
Transducer Orientation
- •
Short-axis to the tendon over the olecranon fossa.
Needle Orientation
- •
Short-axis to the triceps tendon and in-plane to the transducer from a lateral to medial direction.
Target
- •
Directed underneath the triceps tendon and into the joint.
- •
The ulnar nerve should be visualized at the medial epicondyle before the injection to avoid nerve injury.
Ligament Injections
Lateral Collateral Ligament Complex
- •
Most injections can be accomplished using a high-frequency linear ultrasound transducer.
Pertinent Anatomy
- •
Lateral collateral ligament (LCL) complex consists of four ligaments: accessory lateral collateral ligament (ALCL); annular ligament; lateral radial collateral ligament (LRCL); lateral ulnar collateral ligament (LUCL).
- •
LCUL is the primary stabilizer to varus and external rotation stress to the elbow.
Common Pathology
- •
Subtle instability of the LCL complex is challenging to identify on examination, but associated ligament injuries have been reported in up to 20% of cases of lateral epicondylitis. There seems to be a correlation with the severity of the injury to the common extension tendon and LUCL injury.
- •
Associated with a traumatic elbow dislocation, significant injury and instability is detected by conventional physical examination and characterized by mechanical symptoms: that is, clicking or catching.
Equipment
- •
Needle size: 25- or 27-gauge 1- or 1.5-inch needle.
- •
High-frequency linear ultrasound transducer.
Common Injectates
- •
Prolotherapy, orthobiologics (PRP, bone marrow concentrate, etc.).
- •
Avoid intraligamentous corticosteroids.
Injectate Volume
- •
2 to 3 cc.
Technique
Patient Position
- •
Seated or supine position.
- •
Elbow is flexed approximately 90 degrees and the forearm is pronated.
Clinician Position
- •
Seated or standing directly next to the elbow being injected.
Transducer Position
- •
Long-axis or longitudinal to the ligaments.
Needle Position
- •
Four ligaments comprise the LCL complex and the needle position should be adjusted to be in long-axis to the ligaments and in-plane to the transducer.
- •
The LRCL and LUCL should be approached from a distal to proximal orientation.
- •
The ALCL and annular ligament should be approached from a lateral to medial orientation ( Fig. 17.4 ).
Target
- •
Areas of hypoechogenicity and cortical irregularities.
- •
Fenestration of tendon and mild excoriation at sites of cortical irregularities until achieve change in the tissue texture.
- •
Regenerative injection (PRP, adipose-derived stromal cell [ADSC], bone marrow aspirate concentrate [BMAC]) should target areas of hypoechogenicity filling interstitial tears with injectate.
- •
For the ALCL and annular ligament injections, visualize the radial nerve first to avoid injury.
- •
Post-procedure pain medication should be offered and the patient should be informed that pain in the elbow region would likely be increased.
- •
Extremes of range of movement (ROM) should be limited in first 10–12 weeks after the procedure, especially repetitive supination.
- •
Medial Ulnar Collateral Ligament
- •
Most injections can be accomplished using a high-frequency linear ultrasound transducer.
Pertinent Anatomy
- •
Medial ulnar collateral ligament (MUCL) is composed of three bands: anterior band, posterior band, and transverse ligament.
- •
Anterior band is the primary restraint to valgus stress with the elbow in 30–120 degrees of flexion, coursing from the medial epicondyle to the sublime tubercle.
Common Pathology
- •
The MUCL is commonly injured in overhead throwing athletes due to valgus stress on the elbow during the late cocking and early acceleration phases.
Equipment
- •
Needle size: 25- or 27-gauge 1- or 1.5-inch needle.
- •
High-frequency linear ultrasound transducer
Common Injectates
- •
Prolotherapy, orthobiologics (PRP, bone marrow concentrate, etc.),
- •
Avoid intraligamentous corticosteroids
Injectate Volume
- •
2 to 3 cc.
Technique
Patient Position
- •
Supine position.
- •
Elbow and shoulder are flexed to approximately 90 degrees and the forearm is supinated.
Clinician Position
- •
Seated or standing directly next to the elbow being injected.
Transducer Position
- •
Long-axis or longitudinal to the ligaments.
Needle Position
- •
The needle position should be positioned in long-axis to the UCL and in-plane to the transducer.
Target
- •
Areas of hypoechogenicity within the ligament.
- •
Regenerative injection (PRP, ADSC, BMAC) should target areas of hypoechogenicity filling interstitial tears with injectate.
- •
Post-procedure pain medication should be offered and the patient should be informed that pain in the elbow region would likely be increased.
- •
Valgus stress should be limited in first 10–12 weeks after the procedure. Overhead athletes should start a progressive throwing program after the period of rest.
- •
The ulnar nerve should be visualized before the procedure to avoid accidental nerve injury ( Fig. 17.5 ).
Tendon Injections
Common Extensor Tendon
- •
Most injections can be accomplished using a high-frequency linear ultrasound transducer.
Pertinent Anatomy
- •
The tendon originates from the lateral epicondyle of the humerus.
- •
Deep to the common flexor tendon, the radial collateral ligament occupies approximately 50% of the footprint at the lateral epicondyle ( Fig. 17.6 ).
Common Pathology
- •
Lateral epicondylitis is the most common cause of lateral elbow pain.
- •
Typically an overuse syndrome.
- •
Degenerative changes include tendon thickening, intratendinous calcifications, or partial and complete tearing.
Equipment
- •
Needle size: 25- or 27-gauge 1- or 1.5-inch needle.
- •
High-frequency linear ultrasound transducer.
Common Injectates
- •
Local anesthetic plus or minus corticosteroids peritendinous.
- •
Orthobiologics (PRP, bone marrow concentrate, etc.).
- •
Avoid intratendinous corticosteroids.
Injectate Volume
- •
2 to 3 cc.
Technique
Patient Position
- •
Seated or supine position.
- •
Elbow is flexed approximately 90 degrees and the forearm is prone ( Fig. 17.7 ).
Clinician Position
- •
Seated or standing directly next to the elbow being injected.
Transducer Position
- •
Long-axis or longitudinal to the tendon.
Needle Position
- •
Long-axis to the tendon and in-plane to the transducer from a distal to proximal orientation.
Target
- •
Areas of hypoechogenicity and cortical irregularities.
- •
Fenestration of tendon and mild excoriation at sites of cortical irregularities until achieve change in the tissue texture.
- •
Regenerative injection (PRP, ADSC, BMAC) should target areas of hypoechogenicity filling interstitial tears with injectate.
- •
The needle should also be repositioned, moving in a medial to lateral fashion for complete coverage of the enthesis and targeting all areas of hypoechogenicity.
- •
Examine for associated varus instability of lateral collateral complex as associated ligament injuries have been reported in up to 20% of cases of lateral epicondylitis.
- •
Long-term studies have shown that corticosteroid injections are no more beneficial than observation alone and may even have an inferior outcome with higher recurrence rates at 1 year. ,
- •
Avoid intratendinous injection of local anesthetics, especially bupivacaine and lidocaine, as these have been shown to have deleterious effects on progenitor cells. If intratendinous anesthesia is required, then a small amount of 0.125% ropivacaine is preferred.